Global SCADA Market Analysis 2024-2029 Featuring Schneider Electric, Siemens, ABB, Emerson Electric, Rockwell Automation - Integration of SCADA Systems with Big Data Analytics Presenting Opportunities
May 13, 2024 06:39 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global SCADA Market by Component (Programmable Logic Controller (PLC), Remote Terminal Unit (RTU), Human-Machine Interface (HMI), Communication Systems,...
ROHM’s New Energy-Saving DC-DC Converter ICs Offered in the TSOT23 Package
April 23, 2024 17:00 ET
|
ROHM Semiconductor
Santa Clara, CA and Kyoto, Japan, April 23, 2024 (GLOBE NEWSWIRE) -- ROHM Semiconductor today announced four new compact DC-DC step-down converter ICs suitable for consumer and industrial...
Global Ground Penetrating Radars Industry Research 2023-2024 and 2030 - Recovering New Constructions & Renovations to Benefit Demand for GPRs
April 18, 2024 11:49 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Ground Penetrating Radars - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Ground Penetrating...
GigaDevice Launches GD32F5 Series Cortex®-M33 Core MCUs for High-Performance Applications
April 09, 2024 02:30 ET
|
GigaDevice Semiconductor Inc.
NUREMBERG, Germany, April 09, 2024 (GLOBE NEWSWIRE) -- GigaDevice, a leading semiconductor company specializing in Flash Memory, 32-bit Microcontrollers (MCUs), Sensors, and Power Management...
UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
April 03, 2024 07:00 ET
|
Arch Biopartners
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Anesthesia Clinical Trials Unit (ACTU), an...
Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
April 02, 2024 07:26 ET
|
Arch Biopartners
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that three additional clinical sites in Turkey have...
Global Liquid Crystal On Silicon Market by Product (Head Mount Display, Head-Up Display, LCOS Projectors), Technology (Ferroelectrics, Nematics LCOS, Wavelength Selective Switching), Application
March 27, 2024 15:22 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Crystal On Silicon Market by Product (Head Mount Display, Head-Up Display, LCOS Projectors), Technology (Ferroelectrics, Nematics LCOS,...
Loop Calibrators Global Strategic Business Report 2024, Featuring Additel, AMETEK, Fluke Corporation, General Electric, Meriam Process Technologies and Spectris
March 08, 2024 04:10 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Loop Calibrators - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Loop Calibrators...
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
February 16, 2024 11:24 ET
|
F. Hoffmann-La Roche Ltd
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate...
Uveal Melanoma Market Size & Share to Exceed USD 2.5 Billion by 2034, at CAGR of 5.9%. "Shining a Light on Innovation: Revolutionizing the Uveal Melanoma Market for Brighter Tomorrows" – PMI Leads the Way
February 01, 2024 20:30 ET
|
PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Uveal Melanoma Market size was valued at about USD 1.5 Billion in 2024 and expected to grow at CAGR of 5.9% to...